Allison Brashear MD, MBA

Wake Forest University

Allison Brashear, MD, MBA is Professor and Chair of the Department of Neurology at Wake Forest School of Medicine in Winston-Salem, NC (2005-present). She holds the Walter C. Teagle Chair of Neurology. Dr. Brashear also served as Interim Chair of the Department of Psychiatry.

Dr. Brashear is the principal clinician to describe a unique genetic form of dystonia-parkinsonism, Rapid-Onset Dystonia-Parkinsonism (RDP). Her group reported the genetic mechanism responsible for RDP (mutations in the Na/K ATPase alpha 3 subunit) in Neuron in July 2004. In 2008, NINDS funded her group to study these mutations in the ATP1A3 gene in more depth (R01 NS058949; PI: Brashear). This work was refunded in April, 2015 for five years. The results are published in Lancet Neurology, Brain, Neuron, Acta Neuropathologica, Neurology, Annals of Neurology and Movement Disorders. In 2016 Dr. Brashear was appointed a permanent member of the NINDS NST-1 (K awards) study section

Dr. Brashear is the lead principal investigator in many multi-center trials for the treatment of cervical dystonia and spasticity. She is the lead author on the pivotal paper, “Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke”, published in The New England Journal of Medicine. Her work with botulinum toxin has been published in Lancet Neurology, Neurology, Movement Disorders and Archives of PMR.

Dr. Brashear served on the American Academy of Neurology (AAN) Board of Directors from 2013-15. In 2015 she completed six year terms on the AAN Education Committee and the Medical Economic Management Committee. She served on the Board of Directors of the American Neurological Association (ANA), United Council for Neurological Subspecialties (UCNS, vice chair) and currently serves of council of the American Board of University Professors of Neurology (AUPN). In August, 2014 Dr. Brashear was appointed to a renewable four year term as a Director of the American Board of Psychiatry and Neurology (ABPN).

In 2008 the Wake Forest School of Medicine and North Carolina Baptist Hospital integrated to form the Wake Forest Baptist Medical Center. Dr. Brashear served as the first faculty member appointed to the Wake Forest Baptist Medical Center Board of Directors (2007-2013). She also served on the following WFBMC Board of Directors committees: finance, audit, clinical and academic affairs committees. She also serves as one of two faculty members of the WFBMC Capital Campaign Cabinet.